Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients.
暂无分享,去创建一个
A. Gompel | D. Launay | O. Fain | G. Kanny | L. Bouillet | S. Bouée | J. Laurent | Ludovic Martin | V. Montauban | K. Finck | I. Boccon-Gibod
[1] R. Campos,et al. Hereditary angioedema: quality of life in Brazilian patients , 2013, Clinics.
[2] T. Machnig,et al. C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life. , 2012, Allergy and asthma proceedings.
[3] M. Triggiani,et al. Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group , 2012, Allergy.
[4] M. Cicardi,et al. Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21‐month prospective study in a cohort of 103 patients , 2011, Allergy.
[5] W. Lumry,et al. The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. , 2010, Allergy and asthma proceedings.
[6] B. Morgan. Hereditary angioedema--therapies old and new. , 2010, The New England journal of medicine.
[7] P. Keith,et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[8] A. Kaplan,et al. The bradykinin-forming cascade and its role in hereditary angioedema. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[9] A. Bygum,et al. Hereditary angio‐oedema in Denmark: a nationwide survey , 2009, The British journal of dermatology.
[10] T. Craig,et al. Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. , 2009, Allergy and asthma proceedings.
[11] K. Andersen,et al. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. , 2009, European journal of dermatology : EJD.
[12] R. Peebles,et al. The spectrum and treatment of angioedema. , 2008, The American journal of medicine.
[13] K. Bork,et al. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[14] K. Bork,et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.
[15] F. Rosen,et al. Deficiencies of C1 inhibitor. , 2005, Best practice & research. Clinical gastroenterology.
[16] M. López-Trascasa,et al. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[17] A. Tordai,et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.
[18] H. Farkas,et al. Sex hormones in hereditary angioneurotic oedema , 2004, Clinical endocrinology.
[19] A. Stray-Pedersen,et al. Primary Immunodeficiency Diseases in Norway , 2000, Journal of Clinical Immunology.
[20] K. Bork,et al. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. , 2003, Archives of internal medicine.
[21] K. Bork,et al. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. , 2003, The American journal of medicine.
[22] B. Zuraw,et al. Detection of C1 inhibitor mutations in patients with hereditary angioedema. , 2000, The Journal of allergy and clinical immunology.
[23] T. Perneger,et al. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. , 1998, Journal of clinical epidemiology.
[24] M. Cicardi,et al. Plasma bradykinin in angio-oedema , 1998, The Lancet.
[25] M. Borum,et al. Hereditary angioedema. Complex symptoms can make diagnosis difficult. , 1998, Postgraduate medicine.
[26] T. Fest,et al. [Hereditary angioneurotic edema: an underestimated medical emergency. Apropos of 33 cases]. , 1995, Annales de dermatologie et de venereologie.
[27] M. Cicardi,et al. Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.
[28] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[29] G. Lagrue,et al. [Hereditary angioneurotic edema. Recent progress in diagnosis and treatment. Importance of a national registry]. , 1991, Allergie et immunologie.
[30] A. Sheffer,et al. Tranexamic acid therapy in hereditary angioneurotic edema. , 1972, The New England journal of medicine.
[31] G. Lagrue,et al. [Angioneurotic edema of the hereditary type with abnormal serum complement (O.A.N.H.)]. , 1970, La Presse medicale.
[32] W. Osler. HEREDITARY ANGIO‐NEUROTIC ŒDEMA , 1888 .